psychiatric disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have attended the clinic from January 1 to December 31, 2020 (both dates inclusive)
Exclusion criteria
Exclusion criteria: (1)Patients for whom the specified enteral formulas have NOT been prescribed (2)Patients who have been judged as inadequate to entry in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of discontinuation of enteral formulas | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events related to enteral formulas | — |
Countries
Japan
Contacts
EN Otsuka Pharmaceutical, Co., Ltd. R&D Application Office Research & Development Division